Clinical aspects of MuSK antibody positive seronegative MG
Top Cited Papers
- 24 June 2003
- journal article
- Published by Wolters Kluwer Health in Neurology
- Vol. 60 (12) , 1978-1980
- https://doi.org/10.1212/01.wnl.0000065882.63904.53
Abstract
Serum antibodies to muscle-specific receptor tyrosine kinase were detected in 12 of 32 patients with generalized seronegative MG. All were women, with onset between ages 21 and 59 years. Seven had prominent neck, shoulder, or respiratory muscle weakness and little or delayed ocular muscle involvement. The response to cholinesterase inhibitors was variable, and electromyographic findings suggested myopathy in several. None improved after thymectomy. All patients improved after plasma exchange, and most had a good response to selected immunotherapy. MuSK antibody status should help diagnose MG with atypical presentations and ensure appropriate patient treatment.Keywords
This publication has 10 references indexed in Scilit:
- Anti-P110 Autoantibodies Identify a Subtype of “Seronegative” Myasthenia Gravis with Prominent Oculobulbar InvolvementLaboratory Investigation, 2002
- The agrin/muscle‐specific kinase pathway: New targets for autoimmune and genetic disorders at the neuromuscular junctionMuscle & Nerve, 2001
- Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodiesNature Medicine, 2001
- Myasthenia gravisNeurology, 2000
- Macroprolactinemia in Childhood and Adolescence: A Cause of Asymptomatic HyperprolactinemiaHormone Research in Paediatrics, 2000
- Seronegative myasthenia gravisNeurology, 1997
- Clinical heterogeneity of seronegative myasthenia gravisNeuromuscular Disorders, 1996
- Seronegative myasthenia gravis: Clinical features, response to therapy and synthesis of acetylcholine receptor antibodies in vitroJournal of the Neurological Sciences, 1991
- MYASTHENIA GRAVIS WITHOUT ACETYLCHOLINE-RECEPTOR ANTIBODY: A DISTINCT DISEASE ENTITYThe Lancet, 1986
- St. Thomas's Hospital.The Lancet, 1823